The Latest Breaking News from GSK

Foreign equity markets have lagged the U.S. in recent years, making the valuations of overseas stocks attractive.

The Food and Drug Administration granted Moderna's experimental RSV vaccine an expedited review, but Moderna stock dipped Monday.

Rising rates of chronic diseases, an aging population, and increasing healthcare spending should drive the pharma industry’s growth in the upcoming years. Moreover, pharma companies perform steadily regardless of economic conditions due to the inelastic demand for their products. Therefore, it could be wise to invest in fundamentally strong pharma…

Electricians, scaffolders, cable pullers and labourers have downed tools in a dispute over bonus payments.

Six floor office building on New Oxford Street will be workplace for 3,000 staff including CEO

You’d think fund mangers would have deployed degree of scepticism after years of overvalued businesses

About 50,000 federal lawsuits claimed that the best-selling heartburn drug had led to cancer

As of Nov. 11, just 29% of Morningstar-covered stocks that reported Q3 earnings beat estimates by at least 10%.

Brexit fallout plus funding fears mean an uncertain prognosis, but the firm will report good news this week